Image of Rifat Atun, MD, BS

Rifat Atun, M.B.,B.S.

Vice Dean for Non-Degree Education and Innovation, Harvard T.H. Chan School of Public Health
Faculty Lead- International Health Care Systems, Harvard Medical School
Professor of Global Health Systems, Harvard T.H. Chan School of Public Health
Faculty Affiliate in the Department of Health Policy and Management, Harvard T.H. Chan School of Public Health

Dr Rifat Atun is Professor of Global Health Systems at Harvard University and the Faculty Chair for the Harvard Ministerial Leadership Program.

From 2006- to 2013, Dr Atun was Professor of International Health Management and Head of the Health Management Group at Imperial College London. From 2008 to 2012 he served as a member of the Executive Management Team of The Global Fund to Fight AIDS, Tuberculosis and Malaria as the Director of Strategy, Performance and Evaluation Cluster, where he chaired the panel that oversaw investments of around $4billion each year in more than 100 countries.

Dr Atun has published more than 400 papers in leading journals including the Lancet, NEJM, Academy of Management Journal, Lancet Global Health, Lancet Infectious Diseases, Lancet Oncology, and Lancet Psychiatry and PLoS Medicine. He has led or has been a commissioner in 12 Lancet Commissions and was a co-author and member of the Advisory Committee for the Editors for Disease Control Priorities (DCP) 3. In 2020, he was recognized by the Web of Science as one of the World’s Highly Cited Researchers.

Prof. Atun has worked with more than 30 governments globally and with the World Bank, World Health Organization, and the UK Department for International Development (DfID) to design, implement and evaluate health system reform initiatives. In 1999-2006 he was a member of the UK DfID Resource Centre for Health Systems.

Dr Atun has led executive education programs and undertaken assignments for major organizations including Novartis, Medtronic, GSK, Pfizer Inc., the Vodafone Group, and Hofmann-La Roche.

Professor Atun’s research has two major strands. The first examines health systems performance and how design and implementation of health system reforms impact on outcomes. The second strand of research explores adoption and diffusion of innovations in health systems (e.g. new health technologies, disease control programmes, and primary healthcare reforms), and innovative financing in global health. Prof. Atun is a co-Investigator and the joint lead for the innovation work stream at the National Centre for Infection Prevention and Management at Imperial College.

He is also a co-Investigator and the Theme Lead for ‘Organisational Change, Health Economics and Evaluation’ at the NIHR Health Protection Research Unit for Antimicrobial Resistance and Healthcare Associated Infection.

Grass-roots entrepreneurship complements traditional top-down innovation in lung and breast cancer.
Authors: Authors: Ramadi KB, Mehta R, He D, Chao S, Chu Z, Atun R, Nguyen FT.
NPJ Digit Med
View full abstract on Pubmed
Provincial heterogeneity in the management of care cascade for hypertension, diabetes, and dyslipidaemia in China: Analysis of nationally representative population-based survey.
Authors: Authors: Zhao Y, Anindya K, Atun R, Marthias T, Han C, McPake B, Duolikun N, Hulse E, Fang X, Ding Y, Oldenburg B, Lee JT.
Front Cardiovasc Med
View full abstract on Pubmed
Variation in the incidence of type 1 diabetes mellitus in children and adolescents by world region and country income group: A scoping review.
Authors: Authors: Gomber A, Ward ZJ, Ross C, Owais M, Mita C, Yeh JM, Reddy CL, Atun R.
PLOS Glob Public Health
View full abstract on Pubmed
The Prevalence of Islet Autoantibodies in Children and Adolescents With Type 1 Diabetes Mellitus: A Global Scoping Review.
Authors: Authors: Ross C, Ward ZJ, Gomber A, Owais M, Yeh JM, Reddy CL, Atun R.
Front Endocrinol (Lausanne)
View full abstract on Pubmed
Patterns of multimorbidity in India: A nationally representative cross-sectional study of individuals aged 15 to 49 years.
Authors: Authors: Prenissl J, De Neve JW, Sudharsanan N, Manne-Goehler J, Mohan V, Awasthi A, Prabhakaran D, Roy A, Tandon N, Davies JI, Atun R, Bärnighausen T, Jaacks LM, Vollmer S, Geldsetzer P.
PLOS Glob Public Health
View full abstract on Pubmed
Quantifying the primary and secondary effects of antimicrobial resistance on surgery patients: Methods and data sources for empirical estimation in England.
Authors: Authors: Naylor NR, Evans S, Pouwels KB, Troughton R, Lamagni T, Muller-Pebody B, Knight GM, Atun R, Robotham JV.
Front Public Health
View full abstract on Pubmed
Multimorbidity and out-of-pocket expenditure on medicine in Europe: Longitudinal analysis of 13 European countries between 2013 and 2015.
Authors: Authors: Palladino R, Pan T, Mercer SW, Atun R, McPake B, Rubba F, Triassi M, Lee JT.
Front Public Health
View full abstract on Pubmed
Increasing Access to Imaging for Addressing the Global Cancer Epidemic.
Authors: Authors: Hricak H, Ward ZJ, Atun R, Abdel-Wahab M, Muellner A, Scott AM.
Radiology
View full abstract on Pubmed
Punt Politics as Failure of Health System Stewardship: Evidence from the COVID-19 Pandemic Response in Brazil and Mexico.
Authors: Authors: Knaul FM, Touchton M, Arreola-Ornelas H, Atun R, Anyosa RJC, Frenk J, Martínez-Valle A, McDonald T, Porteny T, Sánchez-Talanquer M, Victora C.
Lancet Reg Health Am
View full abstract on Pubmed
The Lancet Commission on diagnostics: transforming access to diagnostics.
Authors: Authors: Fleming KA, Horton S, Wilson ML, Atun R, DeStigter K, Flanigan J, Sayed S, Adam P, Aguilar B, Andronikou S, Boehme C, Cherniak W, Cheung AN, Dahn B, Donoso-Bach L, Douglas T, Garcia P, Hussain S, Iyer HS, Kohli M, Labrique AB, Looi LM, Meara JG, Nkengasong J, Pai M, Pool KL, Ramaiya K, Schroeder L, Shah D, Sullivan R, Tan BS, Walia K.
Lancet
View full abstract on Pubmed